Heart Test Laboratories Inc (HSCS)
0.0888
-0.01
(-6.03%)
USD |
NASDAQ |
May 03, 16:00
0.0898
0.00 (0.00%)
After-Hours: 20:00
Heart Test Laboratories Revenue (Quarterly): 0.0147M for Jan. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 0.0147M |
| October 31, 2023 | 0.0039M |
| July 31, 2023 | |
| April 30, 2023 | |
| January 31, 2023 | 0.0019M |
| October 31, 2022 |
| Date | Value |
|---|---|
| July 31, 2022 | 0.0032M |
| April 30, 2022 | 0.0041M |
| January 31, 2022 | 0.0027M |
| October 31, 2021 | |
| July 31, 2021 | 0.0075M |
| April 30, 2021 | 0.0149M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0019M
Minimum
Jan 2023
0.0149M
Maximum
Apr 2021
0.0066M
Average
0.004M
Median
Revenue (Quarterly) Benchmarks
| Ainos Inc | 0.0199M |
| OpGen Inc | 0.699M |
| Zomedica Corp | 7.337M |
| LENSAR Inc | 12.10M |
| Eargo Inc (DELISTED) | 8.27M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.644M |
| Total Expenses (Quarterly) | 1.540M |
| EPS Diluted (Quarterly) | -0.03 |
| Enterprise Value | -0.7542M |
| Gross Profit Margin (Quarterly) | 68.97% |
| Profit Margin (Quarterly) | -11.18K% |
| Earnings Yield | -540.5% |
| Normalized Earnings Yield | -540.54 |